Legal Opinion

United States ex rel. Dickson v. Bristol-Myers Squibb Co. (In re Plavix Mktg., Sales Practice & Prods. Liab. Litig. (NO. II))

District Court, D. New Jersey

Decided June 27, 2017No. MDL DOCKET NO. 2418; Civil Action No. 13-1039 (FLW)(LHG)PublishedCited by 10 opinions

1Opinion of the Court

WOLFSON, United States District Judge:

Before the Court is the motion of Defendants Bristol-Myers Squibb Company ("BMS"), Sanofi-Aventis U.S. LLC, Sanofi U.S. Service Inc., and Sanofi-Synthelabo Inc. (collectively "Sanofi") (together with BMS, "Defendants") to dismiss the Fourth *933Amended Complaint ("4AC") of relator Elisa Dickson ("Realtor"). In the 4AC, Relator brings a qui tam action, a member case of the Multi-District Litigation, In re: Plavix Marketing, Sales Practices and Products Liability Litigation, involving the alleged wrongful marketing and sales of Plavix (clopidogrel bisulfate), a…

2Cases cited55 opinions

  1. Ashcroft v. IqbalSupreme Court of the United States · 2009
  2. Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
  3. Foman v. DavisSupreme Court of the United States · 1962
  4. Scheuer v. RhodesSupreme Court of the United States · 1974
  5. Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008

50 more not listed; retrieve them via the Exa API.

3Cited by10 opinions

  1. United States ex rel. Simpson v. Bayer Corp.District Court, D. New Jersey · 2019
  2. State ex rel. Balderas v. Bristol-Myers SquibbNew Mexico Court of Appeals · 2018
  3. BENNETT v. BAYER CORPORATIONDistrict Court, D. New Jersey · 2022
  4. BENNETT v. BAYER CORPORATIONDistrict Court, D. New Jersey · 2024
  5. FREEDMAN v. BAYADA HOME HEALTH CARE, INC.District Court, D. New Jersey · 2025

5 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API